122 related articles for article (PubMed ID: 29180001)
1. Effect of the FE
Bernardes JR; Faria CC; Andrade IS; Ferreira ACF; Carvalho DP; Leitão AC; de Alencar TAM; Fortunato RS
Life Sci; 2018 Jan; 192():128-135. PubMed ID: 29180001
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin.
Sheu MT; Jhan HJ; Hsieh CM; Wang CJ; Ho HO
Integr Cancer Ther; 2015 Mar; 14(2):184-95. PubMed ID: 25542609
[TBL] [Abstract][Full Text] [Related]
3. Despite Blocking Doxorubicin-Induced Vascular Damage, Quercetin Ameliorates Its Antibreast Cancer Activity.
Henidi HA; Al-Abbasi FA; El-Moselhy MA; El-Bassossy HM; Al-Abd AM
Oxid Med Cell Longev; 2020; 2020():8157640. PubMed ID: 33728016
[TBL] [Abstract][Full Text] [Related]
4. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
5. Bipyridine (2,2'-dipyridyl) potentiates Escherichia coli lethality induced by nitrogen mustard mechlorethamine.
De Alencar TA; Wilmart-Gonçalves TC; Vidal LS; Fortunato RS; Leitão AC; Lage C
Mutat Res; 2014 Jul; 765():40-7. PubMed ID: 24632511
[TBL] [Abstract][Full Text] [Related]
6. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.
Hoke EM; Maylock CA; Shacter E
Free Radic Biol Med; 2005 Aug; 39(3):403-11. PubMed ID: 15993339
[TBL] [Abstract][Full Text] [Related]
7. Luteolin attenuates doxorubicin-induced cytotoxicity to MCF-7 human breast cancer cells.
Sato Y; Sasaki N; Saito M; Endo N; Kugawa F; Ueno A
Biol Pharm Bull; 2015; 38(5):703-9. PubMed ID: 25947916
[TBL] [Abstract][Full Text] [Related]
8. DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage.
Greenshields AL; Power Coombs MR; Fernando W; Holbein BE; Hoskin DW
Biometals; 2019 Dec; 32(6):909-921. PubMed ID: 31624972
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
10. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.
Li S; Yuan S; Zhao Q; Wang B; Wang X; Li K
Biomed Pharmacother; 2018 Apr; 100():441-447. PubMed ID: 29475141
[TBL] [Abstract][Full Text] [Related]
11. Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells.
Huang X; Dai J; Fournier J; Ali AM; Zhang Q; Frenkel K
Free Radic Biol Med; 2002 Jan; 32(1):84-92. PubMed ID: 11755320
[TBL] [Abstract][Full Text] [Related]
12. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
[TBL] [Abstract][Full Text] [Related]
13. Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death.
Buranrat B; Connor JR
Oncol Rep; 2015 Nov; 34(5):2790-6. PubMed ID: 26352101
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
15. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells.
Koo SW; Casper KA; Otto KB; Gira AK; Swerlick RA
J Invest Dermatol; 2003 May; 120(5):871-9. PubMed ID: 12713595
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines.
Bajbouj K; Shafarin J; Hamad M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764470. PubMed ID: 29562821
[TBL] [Abstract][Full Text] [Related]
17. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS.
Kim DH; Kim JH; Kim EH; Na HK; Cha YN; Chung JH; Surh YJ
Carcinogenesis; 2009 Apr; 30(4):645-54. PubMed ID: 19136476
[TBL] [Abstract][Full Text] [Related]
19. Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
Khan GN; Kim EJ; Shin TS; Lee SH
Anticancer Res; 2017 May; 37(5):2355-2364. PubMed ID: 28476801
[TBL] [Abstract][Full Text] [Related]
20. Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.
Jabłońska-Trypuć A; Świderski G; Krętowski R; Lewandowski W
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
